Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
  • About Us
    • Editorial Profile
    • Editorial Calendar
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
 
 
 
 
  • Despite CRISPR Baby Controversy, Harvard University Will Begin Gene-Editing Sperm

    MIT Technology Review | Even as a furious debate broke out in China over gene-edited babies, some scientists in the US are also hoping to improve tomorrow's children.

    Nov 30, 2018
  • Facing Backlash, Chinese Scientist Defends Gene-Editing Research On Babies

    NPR.org | He Jiankui, who shocked the world by asserting he had genetically edited twin girls, faced growing criticism from other researchers as he spoke at a scientific conference in Hong Kong.

    Nov 28, 2018
  • UberCloud, The Wellcome Sanger Institute, Panasas, And More: News From November 2018

    Bio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including UberCloud, the Wellcome Sanger Institute, Panasas, and more.

    Nov 28, 2018
  • Claim Of CRISPR'ed Baby Girls Stuns Genome Editing Summit

    STAT | A researcher's claim that he used genome editing to alter DNA of human embryos, resulting in the birth a few weeks ago of twin girls, stunned scientists.

    Nov 26, 2018
  • Single-Cell Sequencing Is Opening Up New Avenues For Potential Treatments

    STAT | By quickly analyzing thousands - even millions - of cells, it's now possible to visualize the specific cellular culprits for any given disease.

    Nov 21, 2018
  • «
  • 291
  • 292
  • 293 (current)
  • 294
  • 295
  • 296
  • 297
  • 298
  • 299
  • 300
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: [email protected]

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy